Resultados de procura - Atul Mehta

Limitar resultados
  1. 1
    Glucose-6-phosphate dehydrogenase deficiency

    Glucose-6-phosphate dehydrogenase deficiency por Atul Mehta

    Publicado 1994
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Gaucher disease: haematological presentations and complications

    Gaucher disease: haematological presentations and complications por Alison Thomas, Atul Mehta, Derralynn Hughes

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    How we manage Gaucher Disease in the era of choices

    How we manage Gaucher Disease in the era of choices por Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, Ari Zimran

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura

    Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura por Jo Howard, A. V. Hoffbrand, H. G. Prentice, Atul Mehta

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    A clinical and family history study of Parkinson's disease in heterozygous<i>glucocerebrosidase</i>mutation carriers

    A clinical and family history study of Parkinson's disease in heterozygous<i>glucocerebrosidase</i>mutation carriers por Alisdair McNeill, Raquel Durán, Derralynn Hughes, Atul Mehta, Anthony H.V. Schapira

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  6. 6
    Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation

    Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation por John Goulis, T N Chau, S Jordan, Atul Mehta, A. Watkinson, Keith Rolles, Andrew K. Burroughs

    Publicado 1999
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Evolution of Prodromal Clinical Markers of Parkinson Disease in a<i>GBA</i>Mutation–Positive Cohort

    Evolution of Prodromal Clinical Markers of Parkinson Disease in a<i>GBA</i>Mutation–Positive Cohort por Michelle Beavan, Alisdair McNeill, Christos Proukakis, Derralynn Hughes, Atul Mehta, Anthony H.V. Schapira

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey por Aleš Linhart, Christoph Kampmann, José Luis Zamorano, Gere Sunder‐Plassmann, Michael Beck, Atul Mehta, Perry Elliott

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Clinical prodromes of neurodegeneration in Anderson-Fabry disease

    Clinical prodromes of neurodegeneration in Anderson-Fabry disease por Matthias Löhle, Derralynn Hughes, Alan Milligan, Linda Richfield, Heinz Reichmann, Atul Mehta, Anthony H.V. Schapira

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy

    The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy por Stavros P. Kounas, Camelia Demetrescu, Antonios Pantazis, Andre Keren, Philip Lee, Derralynn Hughes, Atul Mehta, Perry Elliott

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

    Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey por Atul Mehta, Joe T.R. Clarke, Roberto Giugliani, Perry Elliott, Aleš Linhart, Michael Beck, Gere Sunder‐Plassmann

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia

    Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia por Dario Campana, JJ van Dongen, Atul Mehta, Elaine Coustan‐Smith, IL Wolvers-Tettero, K. Ganeshaguru, George Janossy

    Publicado 1991
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation

    Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation por Lucia Lavalle, A. Thomas, Brendan Beaton, H. Ebrahim, Malcolm Reed, Uma Ramaswami, Perry Elliott, Atul Mehta, Derralynn Hughes

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide

    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide por Atul Mehta, Uma Ramaswami, Joseph Muenzer, Roberto Giugliani, Kurt Ullrich, Tanya Collin-Histed, Zoya Panahloo, Hartmann Wellhoefer, Joel Frader

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Fabry disease: a review of current management strategies

    Fabry disease: a review of current management strategies por Atul Mehta, Michael Beck, F. Eyskens, Claudio Feliciani, Ilkka Kantola, Uma Ramaswami, A. Rolfs, A. Rivera, S. Waldek, Dominique P. Germain

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages

    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages por Leonie A. Boven, Marjan van Meurs, Rolf G. Boot, Atul Mehta, Louis Boon, Johannes M. F. G. Aerts, Jon D. Laman

    Publicado 2004
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy

    Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy por Sabrina Nordin, Rebecca Kozor, Heerajnarain Bulluck, Silvia Castelletti, Stefania Rosmini, Amna Abdel‐Gadir, Shanat Baig, Atul Mehta, Derralynn Hughes, James Moon

    Publicado 2016
    Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  18. 18
    Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease

    Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease por Daniel G. Bichet, Johannes M. F. G. Aerts, Christiane Auray‐Blais, Hiroki Maruyama, Atul Mehta, Nina Skuban, Eva Krusinska, Raphael Schiffmann

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages

    Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages por Leonie A. Boven, Marjan van Meurs, Rolf G. Boot, Atul Mehta, Louis Boon, Johannes M. F. G. Aerts, Jon D. Laman

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

    Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis por Michael Beck, Derralynn Hughes, Christoph Kampmann, Sylvain Larroque, Atul Mehta, Guillem Pintos‐Morell, Uma Ramaswami, Michael L. West, Anna Wijatyk, Roberto Giugliani

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: